Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You will need to consult an Accoutant in advance BEFORE you cash out your position! Also you need to be aware that any stock you sell within 6 months of purchase will be will incur Capital Gains Tax at a much HIGHER level than if you sold it at 12 months or longer. Just be aware of that!
If I were you I would Google this and also get in touch with an Accountant.
Be well and prosper...
EXCELLENT ESTIMATE! I concur 100%!
IMO I perceive it could easily be DOUBLE that, i.e. $300 OR even HIGHER with a BigPharma BuyOUT that will come with a change of ticker!
Be well and prosper...
UP 27% early session! Sure, I'll take that any day!
Just snapped up another Mil at market open!
Too bad the penny pinching lookie-loos are still standing on the tracks as the train is roaring to the next post stops of 0.05...0.10..etc!
Be well and prosper...
A great example of this is Cytodyn that was once trading at $10 within the past 52 Weeks....NO product on market and ZERO Earnings. This is but one example of what I was referring to.
Presently it Trades at $2.67 at market close pre-Thanksgiving Day.
What they do have however is their inferior LeronLim Monoclonal Ab, relative to ENCZ's Clone-3, is advancing through clinical trials AND they're partnered with a BigPharma early in the game, so it's likely the combo of these two elements that resulted in their PPS sky rocketing from 0.26 to $10 before pulling back to its present PPS.
Be well and prosper...
EXCELLENT POST!!...as always!
The entire set up is ICING ON THE CAKE!!! It just doesn't get any better than this!
Like I previous posted, IMO our Company should be on NASDAQ right now trading at not less than $6. This is in stark contrast to the Clone-3 Patent being worth $BILLIONS$ all by itself!
Everyone needs to keep in mind that there are both Biotechs & Pharms trading on the major Exchanges that have either NO product on the market and/or no earnings. I've seen it dozens of times and many of them are trading higher than $6.
Be well and prosper...
Sounds good!
50,000 share sold @0.10 would give you $5,000 cash before capital gains tax, then if you let the 600,000 remaining shares ride to $1.00 for $600K or even better yet $2.00 for $1.2 M before tax. It all depends on what your liquid cash needs are at any given time.
Best wishes to you.
Be well and prosper...
Excellent Post!
Thanks you for the feedback and info on the Baker Bros. I'm definitely going to look into that.
IMO just the word-of-mouth leaking out once we get started at Texas A&M in clinical validation studies, etc, just via the network of research investigators and support staff surrounding this project, news will spread like wild fire about what they're working on in the national research drug development community. Many BigPharma's already know about BioClonetics and have probably been watching their development for some time.
Be well and prosper...
The short answer is Disruptive Biotechnology
The more specific answer is exclusive Patent on the Clone-3 Antibody, Monotherapy, ZERO side effects, and the extraordinary capacity to neutralize 95% of ALL known HIV strains worldwide with No "Viral Escape."
Have you performed DD on what BioClonetics's Clone-3 Antibody is all about, and in like manner the same DD on what E.L. and Regeneron has brought to market relative to HIV treatment??
Be well and prosper...
Essentially what everyone is looking at here is a GIANT in the process of "waking up", then when it STANDS UP and begins running, it's going to shock the living daylights out of everyone!
Mark my word, I know what I'm talking about due to having an extensive background in biomedical research and clinical trials involving conducting Pharmaceutical Candidate Drug patient trials for several well known BigPharmas.
Frankly, I've never seen anything like this in my entire career in medicine and biomed research for more than 30 years, and I'm speaking as a published M.D. in peer reviewed medical & scientific journals and also as a Principal Investigator of scores of clinical trials at major University Medical Centers in the U.S.
Happy Thanksgiving
Be well and prosper...
EXCELLENT POST!
Be well and prosper...
EXCELLENT POST!!!
Be well and prosper...
GREAT ADVICE!
Thank you
Be well and prosper...
EXCELLENT POST!!! 100% CORRECT!!!
We're looking at what could arguably become the largest Market Cap Biotech in history to trade on ANY Stock Exchange!
The fundamental reason WHY?
Disruptive Biotechnology due to the proven & validated capacity at 5 major University based Research Centers in the U.S. to Neutralize 95% of ALL known HIV strains worldwide!...AND with ZERO side effects as a Monotherapy! Then to boot, it may have the capacity to do the same thing to Covid-19 due to the structural similarities of these two viruses!
The icing on the cake is the founder of BioClonetics that's about to merge with ENZC any day, has an exclusive Patient on his Clone-3 Ab that can be viewed on the United States Patent Office website! It's the same Patent that Dr. Fauci attempted to steal some years ago, but failed!
This company stock will one day in the near future transition to one of the Major Exchanges and it wouldn't surprise me at all if it eventually trades at a PPS North of $300, possibly a lot higher, OR it will be bought out by a BigPharma before hand!
This stock trading on the OTC is a laughable anomaly! IMO just based on the preliminary validation of Clone-3's effectiveness on HIV it should already be on NASDAQ trading at not less than $6.
LONG & STRONG
Be well and prosper...
That's an EXTREMELY LOW estimate. It should be trading at $6.42 TODAY!!
Nice pull back! Great opportunity to SNAP UP another Mil shares before it moves to 0.05..0.10...etc!
Be well and prosper...
GREAT!!!
I'll just SNAP UP another Mil Shares!
Be well and prosper...
Hey ALL you side-liners and chump change pop-corn flippers....just made ANOTHER $40,000.00 today!...this is the 3rd day in a row same thing!
When are you'all going to GET IT????...next year when it's trading at $10-$15. LOL!
Be well and prosper...
AMEN! That's my plan! BUY/HOLD...BUY/HOLD.. for me it's going to be at any and ALL PPS levels!
Be well and prosper...
Rapidly closing in on 0.05 with a Volume of 165M. Current BUY Vol is 10M Higher than SELL Vol
Likely looking at 0.10 this time next week, possibly higher!
ENZC is breaking through multiple resistance levels!
BUY NOW in this low penny range or you will have to BUY later @1.00 or A LOT HIGHER!!!
DON'T GET LEFT BEHIND!
Be well and prosper...
Current BUY vs SELL Volume going into last hour of market is:
73.4M to 64.4M @0.04
A LOT of accumulation going on today!
By this time next week could be @ 0.10 OR HIGHER!
Cheers!
Be well and prosper...
LOL! Hey, that's what it takes sometimes! I commend your courage and insight!
I know of at least one person that took out a 2nd Mortgage on his house to buy this stock. He dropped at least $100K into it all in one shot! Likely owns at least 10M Shares bought at or near 0.01! LOL!
This is for all you "looky-loos" on the side lines afraid to put your hard earned money in this stock OR you simply don't get it!
I'm a clinical trials profession and academic physician of over 30 years who thoroughly understands what this company has and who's running things behind the scenes, and I can honestly say that to me it is absolutely astonishing what they have and where they're going with it, AND none of this happened overnight.
Their foundational science has been in progress for decades and they are just now at the point where they're ready to roll out to the world what they 've strived for all these years, and they have U.S. Patents on their biotechnology just like Dr. Fauci has on his.
This is a once in a life time opportunity to contribute to a science that actually has a cure for HIV that can bring much needed relief to the world of those who are stricken by this terrible disease, and in doing so you'll make an absolute fortune in the process. It simply doesn't get any better than this.
As for me, I started investing in the stock several months ago, and my ONLY regret is I didn't discover it A LOT sooner this time last year, for reason I would have put at least a Million Dollars into this company based on what I see today, and that is still my intention!
This is NOT your typical OTC Penny Stock, it simply isn't, and the fact that it's on the OTC makes no sense to me whatsoever. The way I see it, the founders could of gotten millions to broker an IPO and taken it directly to NSADAQ or NYSE, but for some reason they didn't.
What you're about to see in the not so distant future is this stock will eventually end up on one of the major exchanges trading at multiples that Biotechs are known for, OR it will be bought out by a Big Pharma before then.
So my point??? Trust your instincts, do your DD and look into what this company is all about. I did when I first stumbled upon it just a few months ago, and I can tell you it took me less than an hour to GET what I was looking and I took the plunge because I knew I couldn't allow my feelings to get in the way about this being an OTC stock, it just didn't add up. I had to separate that from what I knew full well this is.
The result?? I took out a substantial position in this company and will continue adding to that position as often as possible, likely into the million dollar range. Frankly I don't care what the PPS is. It don't care if it's 2 cents, $5, $100, $500, etc it makes no difference to me, and I would still be adding to my position for a long time to come. To me, whatever PPS this stock is trading at is totally irrelevant.
I'm absolutely certain that whatever amount of money I invest in this company's stock it's going to by FAR pay multiples back to me that I will never be about to count, and I will likely give a large sum of it to medical research via a private foundation.
As a healthcare provider, to me money is about "relief of suffering" and helping those who have nothing and are struggling to survive in this world.
I hope this is encouraging to those of you who have not yet taken the plunge. It will likely be the BEST thing you've done in your life both financially and from a humanitarian perspective!
In closing, I must say that it was rather rewarding to see my share position in this company rise by thousands of dollars today just in the first hour of market open and I am aware that there are others here that experience the same thing.
Simply INVEST and forget about it!
LONG & STRONG
Be well and prosper...
Good to see this hit a new 52 Week High of 0.031
...the new "resistance level" but NOT for long!
Next stop 0.05!
Be well and prosper...
Glad I jumped in when I did several months ago!!!
My ENZC portfolio is UP $23,000.00 TODAY just on this small movement sub 0.03!
I say this to encourage anyone and everyone that is not yet in this stock to jump in NOW before you miss a MAMMOTH ride UP well into the $DOLLAR$ range!
Don't go kicking yourself if you miss out on this one!
LONG & STRONG...
Be well and prosper!
AMEN!
Be well and prosper...
Ladies & Gentlemen the TRAIN has left the station!
NEXT STOP > 0.05, then 0.10, 0.15, 0.20, 0.25..0.50...0.75...$1....etc.....$5....
...... SKY'S THE LIMIT ON THIS ONE!!!
Wouldn't be surprise at all if we look up one day and it's trading at $25, $50 post merger!
You're going to see it and REAL SOON!!!!
LONG & STRONG!!
Be well and prosper....
LOL! Serves the penny pinchers right!
Be well and prosper...
An AMAZING Opening 1st 15 mins already moving UP 44.92% heading to 0.03
0.0265
x 10000U +0.0087 (+44.92%)
Bid x size
0.028 x 858000
Ask x size
0.0281 x 80000
Volume
77.00M
Wouldn't be surprised at all if it hits 0.05-0.10 TODAY!
LONG & STRONG....
Be well and prosper...
I thought they put out a news release on June 30, 2020 that they have opted to CEASE all Sec Filings.
https://finance.yahoo.com/news/apt-systems-inc-voluntarily-ceases-225856864.html
Clarify what you are saying here as it contradicts what the above link reveals.
Sounds reasonable!
Be well and prosper...
Yes, thank you for that. I was aware of that specific website page showing the Patents held by Joseph Cotropia several months ago, and at that time I also resourced his Patients on the United States Patent Office website.
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cotropia&FIELD1=INNM&co1=AND&TERM2=Joseph&FIELD2=INNM&d=PALL
Be well and prosper...
Thank you very much for that! Much appreciated!
So based on your great DD on BTG, that would logically mean that any arrangements they previously had with BioClonetics is "Defunct" and did not survive the buyout by Boston Scientific.
Do you concur with this conclusion?
Thanks
Be well and prosper...
I believe it's clear what BTG is and what they do, but it's not very clear to me what the nature of their relationship is to BioClonetics in the overall scope of things.
My discernment however is BTG is a "Patent Broker" (Google that) who invested capital in BioClonetics some time ago in 2002 in exchange for being granted a"Commercializing Patent" to facilitate commercialization of the Clone-3 biotechnology by interfacing directly with BigPharma players.
They clearly stated "we realize value through technology licensing and also patent assertion and sale of equity investments" AND have "commercialized important innovations that include the first monoclonal antibody treatment for Chronic Lymphocytic Leukemia and Recombinant Factor IX blood clotting protein."
A Commercializing Patent is a distinct "Use Patent" that's different from a Utility Patent that categorically includes invention of new technologies.
https://www.stanfordlawreview.org/print/article/commercializing-patents/
Based on this arrangement BioClonetics would maintain exclusive rights to Clone-3 and will license it at some point to a BigPharma for production and global distribution that would typically result in royalities from sales being paid to BioClonetics-Enzc for years to come.
So based on this it appears BTG may be acting a "middle-man" to broker BioClonetics Clone-3 biotechnology to Big Pharma industry giants where the biotechnology licensing rights goes to the highest bidder while BioClonetics retains a large percentage of the royalties? This is only speculation!
My take on this is ONLY my personal opinion but I believe it is a logical qualified opinion based on who BTG says they are and what they do.
I invite perspectives on this by all.
Be well and prosper...
Brilliant!
Be well and prosper...
It appears that 0.02 may be the new resistance level. Any takes on this?
Thanks!
Will likely ADD at a PPS range of 0.013 to 0.015 when profit taking from the trips has run its course for today. It will likely occur in the last hour of trading. If not, no biggie, I'll wait until Monday. Overall, I'll continue BUYING at any and ALL resistance levels!
IMO ANY "copper" range is good to go if you want to be hard core about it!
I will be adding at ALL ranges on its way to paper! Consider it a GIFT!!!
Be well and prosper...
It may be better to wait until end of day to BUY. It's never a good idea to BUY into a run up, especially early into a trading session. Keep in mind that hundreds of traders bought this stock when it was in the 0.000 range, so many of them are now in the process of locking in their profits, and if enough of them do this in a single trading session the PPS will definitely drop. This is not the rule but it is more common than not.
This is only my personal opinion that I generally follow. Also another rule I follow is never BUY in the first hour of any trading session unless you have reason to do so.
Personally, I'm waiting to toward the end of today's trading session to BUY if is looks like it has come back down to its current resistance level of 0.013.
If it comes close to this pps, I will add to my position.
Re: My Post #44758 from today.
Now that Protheragen has been identified as the CRO that's been engaged in moving BioClonetics thru the various phases of candidate drug validation of their Clone-3 Ab (aka: Cl3hmAb seen 5th from the top of Protheragen's Program Pipline Chart on the link below),it's VERY CLEAR that Clone-3 has already passed through the "Discovery" Phase and is presently in the middle of the "Pre-Clinical" Phase that might include the planned Primate Studies at U.C. Davis.
https://www.protheragen.com/
This is extremely good news but for some reason it hasn't made it to public News channels.
When the Pre-Clinical Phase is complete, Clone-3 will then pass through all four industry standard Clinical Trials Phases, i.e. Phase I, II, III, and IV that's required for FDA certification, licensing, and commercialization. Early in this final process the PPS will definitely SOAR well into the Dollar range!!
It's anyone's guess if the chart on the above link is current and up to date, but my hunch is that it won't be long before Clone-3 enters Phase I of Patient Clinical Trials based on what see see on Protheragen's candidate drug development chart.
This paints an enhanced picture of just how far alone BioClonetics has come to bring Clone-3 to market.
I can say it's definitely reassuring to see this.
It may be a good idea to send Protheragen an email and ask them how long ago did BioClonetic's Clone-3 enter their drug development program and what Phase it's presently in.
Be well and prosper...
F.Y.I. to everyone:
Protheragen is what is known as a Contract Research Organization (CRO). Companies like this play a support role to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced to them on a contract basis.
Their role is to facilitate and manage the product development processes of these types of companies on many levels in the overall scope of getting pharmaceuticals or medical devices to market which commonly includes designing, launching, and overseeing clinical trials, but it can also extend to the FDA regulatory and licensing aspects as well.
Some CROs are full service and some are not. Some conduct clinical trials in-house at their own facility and others place clinical trials at various Medical Centers throughout the country that have a dedicated Patient Research Center Unit.
I'm very familiar with this topic due to my professional background as a clinical investigator that interfaced with both CROs and Big Pharma Companies placing candidate drugs trials at Medical Centers where I was based.
Apparently BioClonetics hired Protheragen some time ago to outsource the clinical trials process of their Clone-3 Ab which would explain the reason why much information is now available about it. So logically speaking it appears they have transitioned from "in-vitro" laboratory "Bench" research, to "in-vivo" patient trials for any of this to make sense.
What I discern with Protheragen in the picture is BioClonetics is much further along in their drug development process than previously thought, i.e. they have already transitioned to clinical trials via this CRO. I could be wrong but nothing else would make sense due to the exclusive patent BC has on Clone-3. However it's important to keep in mind that in the pharmaceutical drug development industry, commonly "pilot studies" are conducted on a limited basis before advancing to much larger patient trials.
I hope this helps.
Be well and prosper...
F.Y.I. to everyone:
Protheragen is what is known as a Contract Research Organization (CRO). Companies like this play a support role to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced to them on a contract basis.
Their role is to facilitate and manage the product development processes of these types of companies on many levels in the overall scope of getting pharmaceuticals or medical devices to market which commonly includes designing, launching, and overseeing clinical trials, but it can also extend to the FDA regulatory and licensing aspects as well.
Some CROs are full service and some are not. Some conduct clinical trials in-house at their own facility and others place clinical trials at various Medical Centers throughout the country that have a dedicated Patient Research Center Unit.
I'm very familiar with this topic due to my professional background as a clinical investigator that interfaced with both CROs and Big Pharma Companies placing candidate drugs trials at Medical Centers where I was based.
Apparently BioClonetics hired Protheragen some time ago to outsource the clinical trials process of their Clone-3 Ab which would explain the reason why much information is now available about it.
What I discern with Protheragen in the picture is BioClonetics is much further along in their drug development process than previously thought, i.e. they have already transitioned to clinical trials via this CRO. I could be wrong but nothing else would make sense due to the exclusive patent BC has on Clone-3. However it's important to keep in mind that in the pharmaceutical drug development industry, commonly "pilot studies" are conducted on a limited basis before advancing to much larger patient trials.
I hope this helps.
Be well and prosper...